TyPed study: Natalizumab for the treatment of pediatric-onset multiple sclerosis in Portugal

Filipe Palavra, Sónia Figueiroa, Ana Sofia Correia, Fernando Tapadinhas, João Cerqueira, Rui Pedro Guerreiro, João de Sá, Maria José Sá, Sofia Almeida, Patrícia Mota, Lívia Sousa

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'TyPed study: Natalizumab for the treatment of pediatric-onset multiple sclerosis in Portugal'. Together they form a unique fingerprint.

Medicine & Life Sciences